<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: EMD Serono Staging Battle Against Multiple Sclerosis in Boston, Chief Says</title>
	<atom:link href="http://www.xconomy.com/boston/2009/06/08/emd-serono-staging-battle-against-multiple-sclerosis-in-boston-chief-says/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/06/08/emd-serono-staging-battle-against-multiple-sclerosis-in-boston-chief-says/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 03:54:18 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: EMD Serono chief steps down after MS drug disappointment - Biotech Companies, Jobs, &#38; Research - Biotech Research Institute</title>
		<link>http://www.xconomy.com/boston/2009/06/08/emd-serono-staging-battle-against-multiple-sclerosis-in-boston-chief-says/comment-page-1/#comment-403880</link>
		<dc:creator>EMD Serono chief steps down after MS drug disappointment - Biotech Companies, Jobs, &#38; Research - Biotech Research Institute</dc:creator>
		<pubDate>Fri, 20 May 2011 15:32:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28330#comment-403880</guid>
		<description>[...] to its MS business, which already includes the injected therapy Rebif. Back in June 2009, Firouz told Xconomy about his oral MS hopeful and sounded optimistic that the drug would be an important new treatment [...]</description>
		<content:encoded><![CDATA[<p>[...] to its MS business, which already includes the injected therapy Rebif. Back in June 2009, Firouz told Xconomy about his oral MS hopeful and sounded optimistic that the drug would be an important new treatment [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: David Clivio-Wentrup</title>
		<link>http://www.xconomy.com/boston/2009/06/08/emd-serono-staging-battle-against-multiple-sclerosis-in-boston-chief-says/comment-page-1/#comment-127258</link>
		<dc:creator>David Clivio-Wentrup</dc:creator>
		<pubDate>Tue, 04 May 2010 13:17:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=28330#comment-127258</guid>
		<description>Hello,
I am interested in your research for a personal reason a college friend in California is suffering from MS. He is completely disabled and is basically paralized. he has ask me to research any companies doing current resarch on controling MS. My question is he to far advanced in his MS to become part of your trial? He has had MS for 13 years. An answer would be appriceated thank you for your consideration in this request.</description>
		<content:encoded><![CDATA[<p>Hello,<br />
I am interested in your research for a personal reason a college friend in California is suffering from MS. He is completely disabled and is basically paralized. he has ask me to research any companies doing current resarch on controling MS. My question is he to far advanced in his MS to become part of your trial? He has had MS for 13 years. An answer would be appriceated thank you for your consideration in this request.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

